What is the generic name?

BASILIXIMAB

What is the Trade Name for BASILIXIMAB?

Simulect

What are the Indications for BASILIXIMAB?

• INDICATIONS AND USAGE Simulect ¬Æ (basiliximab) is indicated for the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine, USP (MODIFIED), and corticosteroids. The efficacy of Simulect for the prophylaxis of acute rejection in recipients of other solid organ allografts has not been demonstrated.

References: https://open.fda.gov/